Masters of Business Administration (MBA): A. B. Freeman School of Business, Tulane University, 2015
MD: Cairo University School of Medicine, Cairo, Egypt, 1997
Fellowship: Johns Hopkins University School of Medicine, Maryland, Clinical Fellow in Surgical Endocrinology and Oncology, 2006-2007
Fellowship: State University of New York Health Sciences Center, New York, Department of Surgery, Research Fellow, 2003-2004
Fellowship: New York University Medical Center, NYU Medical Center, New York, Neuroendocrine Research Fellowship, 2000-2001
Residency: Department of Surgery, State University of New York (SUNY) Health Sciences Center- Downstate, 2000–2005
Certification: Educational Commission for Foreign Medical Graduates(ECFMG), 1998
Certification: American Board of Surgery – 2007
2017 Shipley Award Recipient
Dr. Kandil is a Professor of Surgery, the Elias Hanna Chair in Surgery and the Chief of General, Endocrine and Oncological Surgery Division at Tulane University Medical School, New Orleans, LA. He is also an executive member of the Tulane Cancer Executive Council and the director of the clinical Endocrine Surgery Fellowship at Tulane. He completed his training with a clinical fellowship in endocrine surgery at Johns Hopkins University School of Medicine in Baltimore, Maryland. Dr. Kandil is a fellow of the prestigious American Surgical Association and a member of the Southern Surgical Association. He is also a fellow of the American College of Surgeons and the American Association of Clinical Endocrinologists. He serves on several national and international committees and served on multiple institutional leadership positions including being the Chair of General Medical Faculty. Dr. Kandil has written approximately 300 original articles, invited reviews and book chapters and served on numerous editorial boards. Dr. Kandil has a special interest in robotic endocrine surgery and he has the largest experience in the country with robotic thyroid and parathyroid surgery. He has lectured all over the world on topics related to endocrine surgery. Dr. Kandil is the program director of an annual course on thyroid and parathyroid surgery – a program that is now in its 11th year.
His research interests have focused on clinical outcome research related to endocrine surgery. His laboratory research focus is on the identification of novel genetic markers and examining the anti-tumor efficacies of multiple pathways targeting thyroid cancer using in vitro and mouse-model cell in addition to human specimens.
Endocrine tumor genetics and clinical outcome research for thyroid, parathyroid, and adrenal diseases. Dr. Kandil has a funded laboratory. Dr. Kandil’s research team focuses on translational research in thyroid cancer. We have a special interest in active surveillance, we aim to predict which patients may not need any surgical intervention, and which patients will do poorly. We then identify novel targeted therapies directed at the specific genetic mutations in thyroid cancer.
- Robotic-Thyroid & Parathyroid Surgery with no neck scars (Transaxilary, facelift, transoral approaches)
- Intraoperative Nerve Monitoring Technology
- Radio-Guided Minimally Invasive Parathyroid Surgery
- Robotics and Laparoscopic Adrenal Surgery
- Ablation of Thyroid Nodules and Metastatic Disease
- Redo Parathyroid Surgeries and Neck Dissections for Recurrent Diseases
Dr. Kandil makes sure that every patient gets state of the art care while receiving the best compassionate care, just like he would take care of his own family.
View Dr. Kandil's publications on PubMed